Back to search

Article

Ameliorating Ribosylation-induced Aβ Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling

2020-07-07

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Berberine (BBR) plays a neuroprotective role in the pathogenesis of Alzheimer’s disease (AD), inhibiting β-amyloid (Aβ) production and promoting Aβ clearance. Advanced glycation end products (AGEs) promote Aβ aggregation and tau hyperphosphorylation. The activation of mTOR signaling occurring at the early stage of AD has a prominent impact on the Aβ production....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4b765d71-1869-5268-82bd-70ee452eddb6
DOI
10.21203/rs.3.rs-39378/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ameliorating Ribosylation-induced Aβ Pathology by Berberine via Inhibiting mTOR/p70S6K SignalingDOI 10.21203/rs.3.rs-39378/v1
Select a neighboring publication to make it the new centre.